Patent · US Active

EZH2 inhibitors for treating lymphoma

US10166238B2 · kind B2 · utility

10Cited by

10References

19Claims

0Family size

Assignees

Epizyme, Inc. · US
Eisai R&D Management Co., Ltd. · JP

Inventors

Heike KEILHACK · Belmont, US
Sarah K. Knutson · Lincoln, US
Danielle Johnston BLACKWELL · Cambridge, US
Larisa Reyderman · Watchung, US
Lone Ottesen · London, GB

Key dates

Filing date	Jun 17, 2015
Grant date	Jan 1, 2019
Priority date	—
Expiry date	Jun 17, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D405/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to compositions comprising inhibitors of human histone methyltransferase EZH2 and their use for the treatment of cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.